77 related articles for article (PubMed ID: 25495177)
1. Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.
Moses KA; Chen LY; Sjoberg DD; Bernstein M; Touijer KA
BMC Urol; 2014 Dec; 14():98. PubMed ID: 25495177
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
Moreira DM; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Boffetta P; Freedland SJ
Cancer; 2014 Jan; 120(2):197-204. PubMed ID: 24127391
[TBL] [Abstract][Full Text] [Related]
3. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.
Sundi D; Kryvenko ON; Carter HB; Ross AE; Epstein JI; Schaeffer EM
J Urol; 2014 Jan; 191(1):60-7. PubMed ID: 23770146
[TBL] [Abstract][Full Text] [Related]
4. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men.
Epstein M; Syed K; Danella J; Ginzburg S; Belkoff L; Tomaszewski J; Trabulsi E; Singer EA; Jacobs BL; Raman JD; Guzzo TJ; Uzzo R; Reese AC
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):257-263. PubMed ID: 37821578
[TBL] [Abstract][Full Text] [Related]
5. Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.
Cullen J; Young D; Chen Y; Degon M; Farrell J; Sedarsky J; Baptiste W; Rosen P; Tolstikov V; Kiebish M; Kagan J; Srivastava S; Kuo HC; Moncur JT; Rosner IL; Narain N; Akmaev V; Petrovics G; Dobi A; McLeod DG; Srivastava S; Sesterhenn IA
Eur Urol Focus; 2018 Dec; 4(6):818-824. PubMed ID: 28753864
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic.
Bernstein AN; Talwar R; Handorf E; Syed K; Danella J; Ginzburg S; Belkoff L; Reese AC; Tomaszewski J; Trabulsi E; Singer EA; Jacobs B; Kutikov A; Uzzo R; Raman JD; Guzzo T; Smaldone MC; Correa A
JAMA Oncol; 2021 Oct; 7(10):1467-1473. PubMed ID: 34292311
[TBL] [Abstract][Full Text] [Related]
7. Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients.
Park JW; Koh DH; Jang WS; Lee JY; Cho KS; Ham WS; Rha KH; Jung WH; Hong SJ; Choi YD
PLoS One; 2018; 13(6):e0199365. PubMed ID: 29924851
[TBL] [Abstract][Full Text] [Related]
8. Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCH.
Guerrios-Rivera L; Janes JL; De Hoedt AM; Klaassen Z; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ; Fowke JH; Freedland SJ
Cancer Med; 2024 Feb; 13(4):e7012. PubMed ID: 38457188
[TBL] [Abstract][Full Text] [Related]
9. The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.
Cremers RG; Aben KK; van Oort IM; Sedelaar JP; Vasen HF; Vermeulen SH; Kiemeney LA
Prostate; 2016 Jul; 76(10):897-904. PubMed ID: 26989049
[TBL] [Abstract][Full Text] [Related]
10. The impact of marital status on tumor aggressiveness, treatment, and screening among black and white men diagnosed with prostate cancer.
Khan S; Fuzzell L; Langston M; Han Y; Moore JX; Gilbert K; Sutcliffe S; Bensen JT; Mohler JL; Fontham ETH; Song L; Lewis-Thames MW
Cancer Causes Control; 2024 Mar; 35(3):531-539. PubMed ID: 37919455
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in the impact of comorbidities on survival among elderly men with prostate cancer.
Putt M; Long JA; Montagnet C; Silber JH; Chang VW; Kaijun Liao ; Schwartz JS; Pollack CE; Wong YN; Armstrong K
Med Care Res Rev; 2009 Aug; 66(4):409-35. PubMed ID: 19357389
[TBL] [Abstract][Full Text] [Related]
12. Racial variation in the quality of surgical care for prostate cancer.
Barocas DA; Gray DT; Fowke JH; Mercaldo ND; Blume JD; Chang SS; Cookson MS; Smith JA; Penson DF
J Urol; 2012 Oct; 188(4):1279-85. PubMed ID: 22902011
[TBL] [Abstract][Full Text] [Related]
13. Post-diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer.
Khan S; Chang SH; Seyerle AA; Wang M; Hicks V; Drake BF
Prostate; 2023 Sep; 83(12):1150-1157. PubMed ID: 37191401
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological Outcomes.
Sathianathen NJ; Furrer MA; Mulholland CJ; Katsios A; Soliman C; Lawrentschuk N; Peters JS; Zargar H; Costello AJ; Hovens CM; Bishop C; Rao R; Tong R; Steiner D; Moon D; Thomas BC; Dundee P; Calero JAR; Thalmann GN; Corcoran NM
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201549
[TBL] [Abstract][Full Text] [Related]
15. Prognosis after radical prostatectomy in men older than 75 years: long-term results from a single tertiary center.
Lee J; Song J; Jung G; Song SH; Hong SK
Prostate Int; 2024 Mar; 12(1):15-19. PubMed ID: 38523903
[TBL] [Abstract][Full Text] [Related]
16. Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer.
Vidotto T; Imada EL; Faisal F; Murali S; Mendes AA; Kaur H; Zheng S; Xu J; Schaeffer EM; Isaacs WB; Sfanos KS; Marchionni L; Lotan TL
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752203
[TBL] [Abstract][Full Text] [Related]
17. On the Black-White Disparity in Prostate Cancer Mortality.
Brawley OW; Fletcher SA
JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35047753
[No Abstract] [Full Text] [Related]
18. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
Siddiqui MM; Rais-Bahrami S; Turkbey B; George AK; Rothwax J; Shakir N; Okoro C; Raskolnikov D; Parnes HL; Linehan WM; Merino MJ; Simon RM; Choyke PL; Wood BJ; Pinto PA
JAMA; 2015 Jan; 313(4):390-7. PubMed ID: 25626035
[TBL] [Abstract][Full Text] [Related]
19. Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.
Léon P; Seisen T; Cussenot O; Drouin SJ; Cattarino S; Compérat E; Renard-Penna R; Mozer P; Bitker MO; Rouprêt M
Urol Oncol; 2015 Sep; 33(9):384.e21-7. PubMed ID: 25595576
[TBL] [Abstract][Full Text] [Related]
20. Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system.
Daskivich TJ; Kwan L; Dash A; Litwin MS
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):104-9. PubMed ID: 25582624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
